Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10552-007-9003-y.

Title:
NSAIDs and breast cancer recurrence in a prospective cohort study | Cancer Causes & Control
Description:
Objective We examined the association between NSAID use and breast cancer recurrence in a prospective cohort of 2,292 early-stage breast cancer survivors diagnosed from 1997 to 2000 participating in the Life After Cancer Epidemiology (LACE) Study. Methods From 2000 to 2002, mailed questionnaires were used to obtain information on aspirin, ibuprofen, and other NSAID use and subsequent breast cancer events. A total of 270 recurrences (local, regional, and distant disease and new primary breast cancers) were reported and verified by medical record review. Cox proportional hazard models were used to estimate rate ratios (RR) and 95% confidence intervals (CI), adjusting for age at diagnosis, race, cancer stage, tamoxifen treatment, chemotherapy use, body mass index, and cyclooxygenase-2 (COX2) inhibitor use. Results Current, regular use (at least three days per week at time of questionnaire administration) of ibuprofen (RR, 0.56; 95% CI, 0.32–0.98), but not aspirin (RR, 1.09; 95% CI, 0.74–1.61), was associated with a statistically significant decreased risk of breast cancer recurrence. The combination of ibuprofen and other non-aspirin NSAIDs such as naproxen and sulindac reflected a similar reduction in risk (RR, 0.56; 95% CI, 0.33–0.95). No association was found for the non-NSAID analgesic acetaminophen. Conclusion Our findings provide support for an inverse association between current, regular ibuprofen use and breast cancer recurrence.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Education
  • Science

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't tell how the site generates income.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {πŸ”}

cancer, breast, article, google, scholar, pubmed, cas, study, nonsteroidal, antiinflammatory, risk, drugs, cyclooxygenase, aspirin, access, recurrence, cohort, association, privacy, cookies, content, control, prospective, ibuprofen, support, expression, data, information, publish, research, search, nsaids, kwan, slattery, nsaid, regular, open, res, log, journal, april, marilyn, habel, caan, lace, diagnosis, stage, results, women, discover,

Topics {βœ’οΈ}

month download article/chapter steroidal anti-inflammatory drugs keywords anti-inflammatory agents nonsteroidal anti-inflammatory drugs nonsteroidal anti-inflammatory drug spanish multi-case-control breast cancer chemoprevention related subjects full article pdf privacy choices/manage cookies nonsteroidal antiinflammatory drugs breast cancer recurrence prospective cohort study invasive breast cancer breast cancer incidence human breast cancer primary breast cancers breast cancer risk national cancer institute european economic area medical record review estimate rate ratios body mass index hormone receptor status garcia rodriguez la randomized controlled trial rat mammary adenocarcinomas rat mammary carcinomas reis-filho js lymph node metastasis salt lake city breast cancer diagnosis findings provide support cyclo-oxygenase 2 expression conditions privacy policy bmc cancer 3 comparative chemopreventive activity cyclooxygenase-2 gene expression article cancer accepting optional cookies lace study staff utah cancer registry anticancer drug development elevated cyclooxygenase-2 expression author information authors check access instant access article log low-dose aspirin ibuprofen-induced inhibition

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:NSAIDs and breast cancer recurrence in a prospective cohort study
         description:We examined the association between NSAID use and breast cancer recurrence in a prospective cohort of 2,292 early-stage breast cancer survivors diagnosed from 1997 to 2000 participating in the Life After Cancer Epidemiology (LACE) Study. From 2000 to 2002, mailed questionnaires were used to obtain information on aspirin, ibuprofen, and other NSAID use and subsequent breast cancer events. A total of 270 recurrences (local, regional, and distant disease and new primary breast cancers) were reported and verified by medical record review. Cox proportional hazard models were used to estimate rate ratios (RR) and 95% confidence intervals (CI), adjusting for age at diagnosis, race, cancer stage, tamoxifen treatment, chemotherapy use, body mass index, and cyclooxygenase-2 (COX2) inhibitor use. Current, regular use (at least three days per week at time of questionnaire administration) of ibuprofen (RR, 0.56; 95% CI, 0.32–0.98), but not aspirin (RR, 1.09; 95% CI, 0.74–1.61), was associated with a statistically significant decreased risk of breast cancer recurrence. The combination of ibuprofen and other non-aspirin NSAIDs such as naproxen and sulindac reflected a similar reduction in risk (RR, 0.56; 95% CI, 0.33–0.95). No association was found for the non-NSAID analgesic acetaminophen. Our findings provide support for an inverse association between current, regular ibuprofen use and breast cancer recurrence.
         datePublished:2007-04-03T00:00:00Z
         dateModified:2007-04-03T00:00:00Z
         pageStart:613
         pageEnd:620
         sameAs:https://doi.org/10.1007/s10552-007-9003-y
         keywords:
            Anti-inflammatory agents
            Non-steroidal
            Breast neoplasms
            Recurrence
            Chemoprevention
            Cancer Research
            Biomedicine
            general
            Oncology
            Public Health
            Epidemiology
            Hematology
         image:
         isPartOf:
            name:Cancer Causes & Control
            issn:
               1573-7225
               0957-5243
            volumeNumber:18
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Marilyn L. Kwan
               affiliation:
                     name:Kaiser Permanente
                     address:
                        name:Division of Research, Kaiser Permanente, Oakland, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Laurel A. Habel
               affiliation:
                     name:Kaiser Permanente
                     address:
                        name:Division of Research, Kaiser Permanente, Oakland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martha L. Slattery
               affiliation:
                     name:University of Utah
                     address:
                        name:University of Utah, Salt Lake City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bette Caan
               affiliation:
                     name:Kaiser Permanente
                     address:
                        name:Division of Research, Kaiser Permanente, Oakland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:NSAIDs and breast cancer recurrence in a prospective cohort study
      description:We examined the association between NSAID use and breast cancer recurrence in a prospective cohort of 2,292 early-stage breast cancer survivors diagnosed from 1997 to 2000 participating in the Life After Cancer Epidemiology (LACE) Study. From 2000 to 2002, mailed questionnaires were used to obtain information on aspirin, ibuprofen, and other NSAID use and subsequent breast cancer events. A total of 270 recurrences (local, regional, and distant disease and new primary breast cancers) were reported and verified by medical record review. Cox proportional hazard models were used to estimate rate ratios (RR) and 95% confidence intervals (CI), adjusting for age at diagnosis, race, cancer stage, tamoxifen treatment, chemotherapy use, body mass index, and cyclooxygenase-2 (COX2) inhibitor use. Current, regular use (at least three days per week at time of questionnaire administration) of ibuprofen (RR, 0.56; 95% CI, 0.32–0.98), but not aspirin (RR, 1.09; 95% CI, 0.74–1.61), was associated with a statistically significant decreased risk of breast cancer recurrence. The combination of ibuprofen and other non-aspirin NSAIDs such as naproxen and sulindac reflected a similar reduction in risk (RR, 0.56; 95% CI, 0.33–0.95). No association was found for the non-NSAID analgesic acetaminophen. Our findings provide support for an inverse association between current, regular ibuprofen use and breast cancer recurrence.
      datePublished:2007-04-03T00:00:00Z
      dateModified:2007-04-03T00:00:00Z
      pageStart:613
      pageEnd:620
      sameAs:https://doi.org/10.1007/s10552-007-9003-y
      keywords:
         Anti-inflammatory agents
         Non-steroidal
         Breast neoplasms
         Recurrence
         Chemoprevention
         Cancer Research
         Biomedicine
         general
         Oncology
         Public Health
         Epidemiology
         Hematology
      image:
      isPartOf:
         name:Cancer Causes & Control
         issn:
            1573-7225
            0957-5243
         volumeNumber:18
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Marilyn L. Kwan
            affiliation:
                  name:Kaiser Permanente
                  address:
                     name:Division of Research, Kaiser Permanente, Oakland, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Laurel A. Habel
            affiliation:
                  name:Kaiser Permanente
                  address:
                     name:Division of Research, Kaiser Permanente, Oakland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martha L. Slattery
            affiliation:
                  name:University of Utah
                  address:
                     name:University of Utah, Salt Lake City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bette Caan
            affiliation:
                  name:Kaiser Permanente
                  address:
                     name:Division of Research, Kaiser Permanente, Oakland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Causes & Control
      issn:
         1573-7225
         0957-5243
      volumeNumber:18
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Kaiser Permanente
      address:
         name:Division of Research, Kaiser Permanente, Oakland, USA
         type:PostalAddress
      name:Kaiser Permanente
      address:
         name:Division of Research, Kaiser Permanente, Oakland, USA
         type:PostalAddress
      name:University of Utah
      address:
         name:University of Utah, Salt Lake City, USA
         type:PostalAddress
      name:Kaiser Permanente
      address:
         name:Division of Research, Kaiser Permanente, Oakland, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Marilyn L. Kwan
      affiliation:
            name:Kaiser Permanente
            address:
               name:Division of Research, Kaiser Permanente, Oakland, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Laurel A. Habel
      affiliation:
            name:Kaiser Permanente
            address:
               name:Division of Research, Kaiser Permanente, Oakland, USA
               type:PostalAddress
            type:Organization
      name:Martha L. Slattery
      affiliation:
            name:University of Utah
            address:
               name:University of Utah, Salt Lake City, USA
               type:PostalAddress
            type:Organization
      name:Bette Caan
      affiliation:
            name:Kaiser Permanente
            address:
               name:Division of Research, Kaiser Permanente, Oakland, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Research, Kaiser Permanente, Oakland, USA
      name:Division of Research, Kaiser Permanente, Oakland, USA
      name:University of Utah, Salt Lake City, USA
      name:Division of Research, Kaiser Permanente, Oakland, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(86)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.42s.